B
Brian M. Slomovitz
Researcher at University of Miami
Publications - 75
Citations - 2057
Brian M. Slomovitz is an academic researcher from University of Miami. The author has contributed to research in topics: Endometrial cancer & Ovarian cancer. The author has an hindex of 16, co-authored 75 publications receiving 1595 citations. Previous affiliations of Brian M. Slomovitz include University of Texas Health Science Center at Houston & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M. Schmeler,Henry T. Lynch,Lee-may Chen,Mark F. Munsell,Pamela T. Soliman,M. B. Clark,Molly S. Daniels,Kristin G. White,Stephanie Boyd-Rogers,Peggy Conrad,Kathleen Y. Yang,Mary Rubin,Charlotte C. Sun,Brian M. Slomovitz,David M. Gershenson,Karen H. Lu +15 more
TL;DR: It is suggested that prophylactic hysterectomy with bilateral salpingo-oophorectomy is an effective strategy for preventing endometrial and ovarian cancer in women with the Lynch syndrome.
Journal ArticleDOI
Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer.
Michael Frumovitz,Ricardo dos Reis,Charlotte C. Sun,Michael R. Milam,Michael W. Bevers,Jubilee Brown,Brian M. Slomovitz,Pedro T. Ramirez +7 more
TL;DR: Total laparoscopic radical hysterectomy reduces operative blood loss, postoperative infectious morbidity, and postoperative length of stay without sacrificing the size of radical hySterectom specimen margins; however, total Laparoscopicradical hysteretomy is associated with increased operative time.
Journal ArticleDOI
Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer
Michael Frumovitz,Brian M. Slomovitz,Diljeet K. Singh,Russell R. Broaddus,Jacki Abrams,Charlotte C. Sun,Michael W. Bevers,Diane C. Bodurka +7 more
TL;DR: Until better markers of lymphatic spread exist, complete surgical staging of all patients with endometrial cancer is recommended, and the combination of intraoperative frozen section analysis for histologic grade and depth of myometrial invasion does not correlate well with final pathologicgrade and stage.
Journal ArticleDOI
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
Johann S. de Bono,Nicole Concin,David S. Hong,Fiona C Thistlethwaite,Jean-Pascal Machiels,Hendrik Tobias Arkenau,Ruth Plummer,Robert H. Jones,Dorte Nielsen,Kristian Windfeld,S. Ghatta,Brian M. Slomovitz,James Spicer,Jeffrey Yachnin,Joo Ern Ang,Paul Morten Mau-Sørensen,Martin Forster,D. Collins,Emma Dean,Reshma A. Rangwala,Ulrik Lassen +20 more
TL;DR: This trial aimed to establish the safety, tolerability, pharmacokinetic profile, and antitumour activity of tisotumab vedotin in a mixed population of patients with locally advanced or metastatic solid tumours known to express tissue factor.
Journal ArticleDOI
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.
Amir A. Jazaeri,Emese Zsiros,Rodabe N. Amaria,Andrew S. Artz,Robert P. Edwards,Robert M. Wenham,Brian M. Slomovitz,Axel Walther,Sajeve Samuel Thomas,Jason Chesney,Robert T. Morris,Koji Matsuo,Stephanie Gaillard,Peter G. Rose,Jesus Garcia Donas,Jacqueline M. Tromp,Fatemeh Tavakkoli,Huiling Li,Maria Fardis,Bradley J. Monk +19 more
TL;DR: A large number of patients with recurrent, metastatic, or persistent cervical cancer are young and survival rates are low, so there is a high unmet medical need for effective treatments.